Suganthi Balasubramanian - Apr 3, 2023 Form 3 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role
10%+ Owner
Signature
/s/ Suganthi Balasubramanian
Stock symbol
BTAI
Transactions as of
Apr 3, 2023
Transactions value $
$0
Form type
3
Date filed
4/14/2023, 11:30 AM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BTAI Common Stock 8.55M Apr 3, 2023 By BioXcel LLC
holding BTAI Common Stock 1K Apr 3, 2023 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person may be deemed to share investment control over shares of common stock of the Issuer held by BioXcel and 1,000 additional shares of common stock held in a trust. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of her pecuniary interest therein, if any. This filing shall not be deemed an admission that the Reporting Person is the beneficial owner of any such shares of common stock for the purpose of Section 16 or for any other purpose.